Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age Scoped for Japanese
AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)
Sponsor: Pfizer
Listed as NCT01897766, this observational or N/A phase trial focuses on Small for Gestational Age (SGA) and remains completed. Sponsored by Pfizer, it has been updated 13 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
-
Jan 2023 — Oct 2023 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Mar 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2017 — May 2017 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Mar 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.